Table 1. Clinical characteristics of 177 patients with DLBCL.
Clinical characteristic | DLBCL (NOS) | Primary DLBCL of CNS or Testis | |||
---|---|---|---|---|---|
Cases | Percent (%) | Cases | Percent (%) | ||
Age | <60 | 117 | 70.90 | 10 | 83.33 |
>=60 | 48 | 29.10 | 2 | 16.67 | |
Gender | Female | 76 | 46.06 | 5 | 41.67 |
Male | 89 | 53.94 | 7 | 58.33 | |
Ann Arbor stage | 1~2 | 78 | 47.27 | 4 | 33.33 |
3~4 | 87 | 52.73 | 8 | 66.67 | |
B symptoms | No | 101 | 61.21 | 9 | 75.00 |
Yes | 64 | 38.79 | 3 | 25.00 | |
LDH | Normal | 74 | 44.85 | 9 | 75.00 |
Elevated | 91 | 55.15 | 3 | 25.00 | |
ECOG | 0~1 | 123 | 74.55 | 8 | 66.67 |
>=2 | 42 | 25.45 | 4 | 33.33 | |
Massive mass | No | 155 | 93.94 | 12 | 100.00 |
Yes | 10 | 6.06 | 0 | 0.00 | |
IPI | 0~1 | 74 | 44.85 | 6 | 50.00 |
2~3 | 73 | 44.24 | 5 | 41.67 | |
4~5 | 18 | 10.91 | 1 | 8.33 | |
Extranodal involvement | 0-1 | 118 | 71.52 | 8 | 66.67 |
>=2 | 47 | 28.48 | 4 | 33.33 | |
Response* | CR | 77 | 46.67 | 5 | 41.67 |
PR | 61 | 36.97 | 4 | 33.33 | |
SD | 6 | 3.63 | 0 | 0.00 | |
PD | 21 | 12.73 | 3 | 25.00 |
assessed after 4 cycles of chemotherapy